ENOB Enochian Biosciences, Inc.

Enochian BioSciences Inc is an immunotherapy company engaged in developing cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccine and cures and Cellular immune-oncology products.

$9.04  +0.40 (4.63%)
As of 10/18/2021 15:59:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/02/2015
Outstanding shares:  52,219,661
Average volume:  239,093
Market cap:   $430,812,203
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    29350E104
ISIN:        US29350E1047
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.58
PS ratio:   0.00
Return on equity:   -15.30%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy